The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

被引：0

作者：

Lazarian, Gregory ^{[1
]}

Theves, Floriane ^{[2
]}

Hormi, Myriam ^{[1
]}

Eclache, Virginie ^{[1
]}

Poulain, Stephanie ^{[3
]}

Bidet, Audrey ^{[4
]}

Pastoret, Cedric ^{[5
]}

Veronese, Lauren ^{[6
]}

Delabesse, Eric ^{[7
]}

Estienne, Marie-Helene ^{[8
]}

Nadal, Nathalie ^{[9
]}

Davi, Frederic ^{[10
]}

Nguyen-Khac, Florence ^{[11
]}

Lode, Laurence ^{[12
]}

Sujobert, Pierre ^{[13
]}

Naguib, Dina ^{[14
]}

Raynaud, Sophie ^{[15
]}

Giraudier, Stephane ^{[16
]}

Kosmider, Olivier ^{[17
]}

Etancelin, Pascaline ^{[18
]}

Cornillet-Lefebvre, Pascale ^{[19
]}

Miguet, Laurent ^{[20
]}

Leblond, Veronique ^{[21
]}

Letestu, Remi ^{[1
]}

Soussi, Thierry ^{[22
,23
]}

Cymbalista, Florence ^{[1
]}

Baran-Marszak, Fanny ^{[1
]}

机构：

[1] Hop Avicenne, APHP, Lab Hematol, Bobigny, France

[2] APHP Pitie Salpetriere, Paris, France

[3] CHRU Lille, Ctr Biol & Pathol, Serv Hematol Cellulaire, INSERM UMR 1172, Lille, France

[4] CHU Bordeaux, Pessac, France

[5] Univ Hosp Rennes, INSERM U1236, Hematol Lab, Rennes, France

[6] Univ Hosp Clermont Ferrand, Cytogenet Lab, Clermont Ferrand, France

[7] Inst Univ Canc Toulouse Oncopole, Hematol Lab, Toulouse, France

[8] Tours Univ Hosp, Tours, France

[9] Univ Hosp, Dept Genet, Dijon, France

[10] Hop La Pitie Salpetriere, APHP, Paris, France

[11] APHP Pitie Salpetriere, Hematol Biol, Paris, France

[12] CHU Montpelier, Lab Hematol, Montpellier, France

[13] Hosp Civils Lyon, Dept Biol, Ctr Hosp Lyon Sud, Pierre Benite, France

[14] CHU Caen Normandie, Lab Hematol, Caen, France

[15] CHU Nice, Pasteur Hosp, Nice, France

[16] Univ Paris, Inst Rech St Louis, UMRS 1131, INSERM, Paris, France

[17] Hop Cochin, Asistance Publ Hop Paris, Lab Hematol, Paris, France

[18] Ctr Henri Becquerel, Rouen, France

[19] Reims Univ Hosp, Hematol Biol, Reims, France

[20] Hop Hautepierre, Lab Hematol, Strasbourg, France

[21] Sorbonne Univ, Serv Hematol, Hop Pitie Salpetriere, Paris, France

[22] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[23] UPMC, INSERM, Paris, France

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-130907

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3021

引用

页数：4

共 50 条

[1] Extraneural Metastasis of Glioblastoma and TP53 Pathogenic Variants
Zhang, Xiaoming
Katsakhyan, Levon
LiVolsi, Virginia
Roth, Jacquelyn
Rassekh, Christopher
Bagley, Stephen
Nasrallah, MacLean
[J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 575 - 575
[2] TP53 or Not TP53: That Is the Question
Green, Steven D.
Zeidner, Joshua F.
[J]. CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5235 - 5237
[3] Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary
Beird, Hannah C.
Lin, Dimitri
Lazar, Alexander J.
Futreal, P. Andrew
[J]. JOURNAL OF PATHOLOGY, 2024, 263 (02): : 131 - 134
[4] Germline TP53 Variants and Susceptibility to Osteosarcoma
Mirabello, Lisa
Yeager, Meredith
Mai, Phuong L.
Gastier-Foster, Julie M.
Gorlick, Richard
Khanna, Chand
Patino-Garcia, Ana
Sierrasesumaga, Luis
Lecanda, Fernando
Andrulis, Irene L.
Wunder, Jay S.
Gokgoz, Nalan
Barkauskas, Donald A.
Zhang, Xijun
Vogt, Aurelie
Jones, Kristine
Boland, Joseph F.
Chanock, Stephen J.
Savage, Sharon A.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07)
[5] Rare Variants in TP53 and Susceptibility to Neuroblastoma
Diskin, Sharon J.
Capasso, Mario
Diamond, Maura
Oldridge, Derek A.
Conkrite, Karina
Bosse, Kristopher R.
Russell, Mike R.
Iolascon, Achille
Hakonarson, Hakon
Devoto, Marcella
Maris, John M.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (04)
[6] Second Specimen Testing for TP53 Variants
Bissonnette, J.
Marshall, M.
Barber, K.
Klein, R. T.
Zhao, J.
Hruska, K. S.
[J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 952 - 952
[7] Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants
Schwartz, Alison N.
Hyman, Sophie R.
Stokes, Samantha M.
Castillo, Danielle
Tung, Nadine M.
Weitzel, Jeffrey N.
Rana, Huma Q.
Garber, Judy E.
[J]. JCO PRECISION ONCOLOGY, 2021, 5 : 1677 - 1686
[8] Concern regarding classification of germline TP53 variants as likely pathogenic
Evans, D. Gareth
Turnbull, Clare
Woodward, Emma R.
[J]. HUMAN MUTATION, 2019, 40 (06) : 828 - 831
[9] Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants
Petry, Vanessa
[J]. CANCER RESEARCH, 2021, 81 (04)
[10] Germline TP53 pathogenic variants and breast cancer: A narrative review
Blondeaux, Eva
Arecco, Luca
Punie, Kevin
Graffeo, Rossella
Toss, Angela
De Angelis, Carmine
Trevisan, Lucia
Buzzatti, Giulia
Linn, Sabine C.
Dubsky, Peter
Cruellas, Mara
Partridge, Ann H.
Balman, Judith
Paluch-Shimon, Shani
Lambertini, Matteo
[J]. CANCER TREATMENT REVIEWS, 2023, 114

← 1 2 3 4 5 →